Therapy News and Research

RSS

Abbott declares quarterly dividend of 40 cents per share

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2009.

27 Jan 2010

Home health care fraud: Detroit-area physical therapist pleads guilty

Detroit-area resident Jessica Vigil pleaded guilty today for her role in a Detroit-area home health care fraud scheme, announced Assistant Attorney General Lanny Breuer of the Criminal Division; U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office; and Special Agent in Charge Lamont Pugh III of the U.S. Department of Health and Human Services, Office of the Inspector General's (HHS-OIG) Chicago Region.

27 Jan 2010

Pediatricians need to refer children with suspected delays for further testing or treatment and follow up

Many pediatricians score high on screening their patients for developmental delays, but barely make a passing grade in referring children with suspected delays for further testing or treatment, according to a study from Johns Hopkins Children's Center and other institutions to appear in the February issue of Pediatrics.

27 Jan 2010

EU Clinical Trials Directive: ECCO supports proposals by its member organisations

In response to a European Commission consultation on the EU Clinical Trials Directive, ECCO - the European CanCer Organisation - has supported proposals by its member organisations for adapting the Directive's requirements to reflect practical necessities in cancer research and treatment.

27 Jan 2010

Treating septic shock patients with intensive insulin therapy does not reduce risk of in-hospital death

Treating adults with septic shock with intensive insulin therapy to counter elevated blood glucose levels associated with corticosteroid therapy did not result in a reduced risk of in-hospital death, compared to patients who received conventional insulin therapy, according to a study in the January 27 issue of JAMA.

27 Jan 2010

Spectrum Pharmaceuticals discontinues the development of ozarelix in BPH

Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it is discontinuing development of ozarelix in benign prostatic hypertrophy (BPH).

27 Jan 2010

AFib: NAVISTAR THERMOCOOL Catheter provides better outcomes compared to drug therapy

According to data appearing today in JAMA, patients with a common heart rhythm disorder, called Atrial Fibrillation, who were treated with catheter ablation using the NAVISTAR® THERMOCOOL® Catheter, demonstrated significantly better outcomes at one year compared to those receiving drug therapy. In addition, the patients treated with catheter ablation reported markedly fewer symptoms and substantially improved quality of life.

27 Jan 2010

Researchers join in a three-year project to pursue novel applications of HPC in radiotherapy

Researchers from the San Diego Supercomputer Center (SDSC) at UC San Diego have joined forces with the Department of Radiation Oncology in the university's School of Medicine, its Department of Mathematics, and the Lawrence Livermore National Laboratory (LLNL) in a three-year, $1.5 million project to pursue novel applications of high-performance computing (HPC) in radiotherapy.

27 Jan 2010

Mayo Clinic achieves new levels of excellence in service to humanity

Mayo Clinic announced today that it raised $1.35 billion in its first comprehensive fundraising campaign, surpassing the goal of $1.25 billion.

27 Jan 2010

Extensive gap exists between primary care practice and obesity care

Using combined and intensive treatments and restructuring care to treat obesity like other chronic diseases may help primary care clinicians and patients better address the condition, according to a commentary and three articles published in the January 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Jan 2010

Regular exercise associated with greater longevity and reduced risk of age-related conditions

Physical activity appears to be associated with a reduced risk or slower progression of several age-related conditions as well as improvements in overall health in older age, according to a commentary and four articles published in the January 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Jan 2010

Proteomics study reveals protein suppression makes cancers more susceptible to chemotherapy

Taxanes, a group of cancer drugs that includes paclitaxel (Taxol-) and docetaxel (Taxotere-), have become front-line therapy for a variety of metastatic cancers. But as with many chemotherapy agents, resistance can develop, a frequent problem in breast, ovarian, prostate and other cancers.

27 Jan 2010

Trial results show primary care doctors are capable of helping obese patients to lose weight

Despite a general belief among physicians that extreme obesity is too difficult to treat, except with bariatric surgery, researchers at the Pennington Biomedical Research Center have learned a substantial proportion of individuals with extreme obesity can lose 10-percent or more of their body weight through medical treatment that does not include surgery.

27 Jan 2010

New disease management initiative in Colorado aims to treat low back pain and improve patient outcomes

HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that by increasing the role of the primary-care physician, the recently launched Colorado Low Back Collaborative (CLBC) aims to treat lower back issues with a more holistic view, and ultimately improve patient outcomes while lowering costs associated with the care of low back pain.

27 Jan 2010

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The

27 Jan 2010

MU researcher develops EFdA compound that is more potent than current HIV therapies

With the help of effective drug therapies, HIV patients are living longer, healthier lives. Now, researchers want to improve these drug therapies and develop alternative preventative strategies, such as vaginal gels and creams that contain the same or related compounds used in treatments for people infected with HIV.

27 Jan 2010

USAN approves generic name "ulimorelin" for Tranzyme Pharma's TZP-101

Tranzyme Pharma today announced that the United States Adopted Name Council (USAN) has approved the generic name “ulimorelin” for Tranzyme’s novel, late-stage, prokinetic agent TZP-101. Ulimorelin, if approved, is expected to be a first-in-class drug for the treatment of gastrointestinal (GI) dysmotility indications in acute care (hospital-based) settings.

27 Jan 2010

Geron collaborates to explore hESC-based product for Alzheimer’s disease

Geron Corporation today announced that it has entered into a collaboration jointly funded by Geron and a University of California Discovery Research and Training Grant to investigate the therapeutic potential of its human embryonic stem cell (hESC)-based product, GRNOPC1, for Alzheimer’s disease. The company is currently developing GRNOPC1 for the potential treatment of spinal cord injury.

27 Jan 2010

Antioxidants can also harm

Antioxidants increasingly have been praised for their benefits against disease and aging, but recent studies at Kansas State University show that they also can cause harm.

27 Jan 2010

Potential risk factors in skipping insulin injections

More than half of people with diabetes who take insulin injections to control their diabetes say they have intentionally skipped an injection, with one-fifth of them reporting that they do so "sometimes" or "often," according to a study being published this month in Diabetes Care.

27 Jan 2010

Therapy News and Research

Abbott declares quarterly dividend of 40 cents per share

Home health care fraud: Detroit-area physical therapist pleads guilty

Pediatricians need to refer children with suspected delays for further testing or treatment and follow up

EU Clinical Trials Directive: ECCO supports proposals by its member organisations

Treating septic shock patients with intensive insulin therapy does not reduce risk of in-hospital death

Spectrum Pharmaceuticals discontinues the development of ozarelix in BPH

AFib: NAVISTAR THERMOCOOL Catheter provides better outcomes compared to drug therapy

Researchers join in a three-year project to pursue novel applications of HPC in radiotherapy

Mayo Clinic achieves new levels of excellence in service to humanity

Extensive gap exists between primary care practice and obesity care

Regular exercise associated with greater longevity and reduced risk of age-related conditions

Proteomics study reveals protein suppression makes cancers more susceptible to chemotherapy

Trial results show primary care doctors are capable of helping obese patients to lose weight

New disease management initiative in Colorado aims to treat low back pain and improve patient outcomes

Investigators identify new disease mechanism and therapeutic approach for lupus kidney disease

MU researcher develops EFdA compound that is more potent than current HIV therapies

USAN approves generic name "ulimorelin" for Tranzyme Pharma's TZP-101

Geron collaborates to explore hESC-based product for Alzheimer’s disease

Antioxidants can also harm

Potential risk factors in skipping insulin injections

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News